Inogen Inc reports results for the quarter ended March 31 - Earnings Summary

Inogen

08/05/2025 06:38

Inogen Inc INGN.OQ reported a quarterly adjusted loss of 25 cents​​ per share for the quarter ended March 31, higher than the same quarter last year, when the company reported EPS of -62 cents.  The mean expectation of four analysts for the quarter was for a loss of 50 cents per share. Wall Street expected results to range from -66 cents to -40 cents per share.

Revenue rose 5.5% to $82.28 million from a year ago; analysts expected $79.55 million.

Inogen Inc's reported EPS for the quarter was a loss of 25 cents​.

The company reported a quarterly loss of $6.17 million.

Inogen Inc shares had risen by 0.6% this quarter and lost 21.8% so far this year.

FORECAST CHANGES

The mean earnings estimate of analysts had risen by about 7.3% in the last three months.​

In the last 30 days, there have been no negative revisions of earnings estimates

RECOMMENDATIONS

The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy," 2 "hold" and 1 "sell" or "strong sell." The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "hold"

Wall Street's median 12-month price target for Inogen Inc is $7.00

This summary was machine generated from LSEG data May 8 at 05:38 a.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDING
ESTIMATE
ACTUAL
BEAT, MET, MISSED
Mar. 31 2025
-0.50
-0.25
Beat
Dec. 31 2024
-0.61
-0.41
Beat
Sep. 30 2024
-0.49
-0.25
Beat
Jun. 30 2024
-0.54
-0.24
Beat